Efficacy and Safety of Avutometinib ± Defactinib in Recurrent Low-Grade Serous Ovarian Cancer: Primary Analysis of ENGOT-OV60/GOG-3052/RAMP 201.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025 · 42 citations · Robert Holloway
An Overview of Endometrial Cancer with Novel Therapeutic Strategies.
Current oncology (Toronto, Ont.) · 2023 · 39 citations · Theresa Kuhn
Sentinel lymph node biopsy in high-grade endometrial cancer: a systematic review and meta-analysis of performance characteristics.
American journal of obstetrics and gynecology · 2021 · 65 citations · Robert Holloway
Post-surgical ctDNA-based molecular residual disease detection in patients with stage I uterine malignancies.
Gynecologic oncology · 2024 · 31 citations · Robert Holloway
Rucaparib for maintenance treatment of platinum-sensitive, recurrent ovarian carcinoma: Final results of the phase 3, randomized, placebo-controlled ARIEL3 trial.
European journal of cancer (Oxford, England : 1990) · 2025 · 15 citations · Robert Holloway
Cediranib in Combination with Olaparib in Patients without a Germline BRCA1/2 Mutation and with Recurrent Platinum-Resistant Ovarian Cancer: Phase IIb CONCERTO Trial.
Clinical cancer research : an official journal of the American Association for Cancer Research · 2022 · 49 citations ·
Clinical Activity of Olvimulogene Nanivacirepvec-Primed Immunochemotherapy in Heavily Pretreated Patients With Platinum-Resistant or Platinum-Refractory Ovarian Cancer: The Nonrandomized Phase 2 VIRO-15 Clinical Trial.
JAMA oncology · 2023 · 37 citations · Robert Holloway, James Kendrick, Nathalie McKenzie
Sentinel lymph node (SLN) isolated tumor cells (ITCs) in otherwise stage I/II endometrioid endometrial cancer: To treat or not to treat?
Gynecologic oncology · 2021 · 45 citations · Robert Holloway